Tuberculosis, Pulmonary clinical trials

The registry lists 319 studies for Tuberculosis, Pulmonary across more than 10 countries. 71 are recruiting or about to start. 268 of them are mainly about Tuberculosis, Pulmonary (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10.

Get an email when these change. Save the Tuberculosis, Pulmonary studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies

See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed: 174
Recruiting: 45
Status unknown: 42
Not yet recruiting: 24
Active, not recruiting: 11
Terminated: 10

Phase

Phase 2: 95
Phase 3: 45
Phase 1: 28
Phase 4: 16
Early Phase 1: 2

Where

South Africa: 78
China: 28
United States: 26
India: 26
Uganda: 24
Tanzania: 17

Who runs them

Global Alliance for TB Drug Development (22) · National Institute of Allergy and Infectious Diseases (NIAID) (15) · Michael Hoelscher (9) · Johns Hopkins University (7) · TASK Applied Science (6) · Beijing Chest Hospital (6) · Seoul National University Hospital (6) · Foundation for Innovative New Diagnostics, Switzerland (5)

What is being tested here

Drugs under test in Tuberculosis, Pulmonary studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug	Open	Phase 3	All
Moxifloxacin	6	8	15
Bedaquiline	5	12	22
Pyrazinamide	5	5	16
Linezolid	4	9	15
Rifapentine	3	5	8
Sitafloxacin	3	3	3
Atorvastatin	3	1	3
Rifampin	2	3	17
Pretomanid	2	6	16
BTZ-043	2	0	5

Drug classes tested here Statins 3 open · Beta-lactamase inhibitors 1 open

Coming up

19phase 3 studies under way

26studies finish main data collection within a year4 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Dec 2026Short-course Regimens for the Treatment of Pulmonary Tuberculosis · Phase 3 · Centers for Disease Control and Prevention
Dec 2026Pragmatic Optimized Rifampicin Trial · Phase 3 · Radboud University Medical Center
Feb 2027Innovating Shorter, All- Oral, Precised Treatment Regimen for Rifampicin Resistant Tuberculosis：BDLL Chinese Cohort · Phase 3 · Huashan Hospital
Sep 2027Shortened Regimen for Drug-susceptible TB in Children · Phase 3 · Johns Hopkins University
Nov 2026Bactericidal Activity of TBD09 in Combination With Other Drugs in Pulmonary Tuberculosis · Gates Medical Research Institute
Nov 2026Effectiveness of Psychosocial Counseling in Patients With a New Tuberculosis Diagnosis · Universitas Diponegoro
Nov 2026Channa Striata and Curcuma Domestica Supplementation in Patients With Active Pulmonary Tuberculosis · DINA KEUMALA SARI
Dec 2026Remimazolam for Bronchoscopy in High-Risk Patients · First Affiliated Hospital of Zhejiang University
Dec 2026ID93+GLA-SE Vaccine Against Tuberculosis in Older Adults Aged 55-74 · Quratis Inc.
Dec 2026Characterization of Tuberculosis Associated Lung Fibrosis and Respiratory Impairment, and Prevention Using Doxycycline · Makerere University

Who these studies take

Of the 45 Tuberculosis, Pulmonary studies recruiting now, 21 (47%) set no upper age limit and 20 (44%) stop at 75 or younger. 11 (24%) take children under 18. 0 (0%) are for women only and 1 (2%) for men only; 7 (16%) take healthy volunteers.

Recruiting studies that take each age, of 45
Age	Women	Men
10	6 (13%)	6 (13%)
18	38 (84%)	38 (84%)
30	38 (84%)	39 (87%)
40	39 (87%)	40 (89%)
50	38 (84%)	39 (87%)
65	38 (84%)	38 (84%)
75	25 (56%)	25 (56%)
85	23 (51%)	23 (51%)

Across all 319 studies, recruiting or not: 42% stop at 75 or younger and 34% at 65; 22% take children; 1% are for women only and 2% for men only; 19% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Tuberculosis, Pulmonary studies take

Of 43 phase 2 interventional studies under Tuberculosis, Pulmonary, half reached primary completion within 30 months of starting, counting those still running.

Start to primary completion	Every sponsor	Industry	Non-industry
Phase 1	3 mo2–13 · 13 studies	—	—
Phase 2	30 mo21–37 · 43 studies	—	30 mo21–49 · 33 studies
Interventional, no phase	17 mo11–29 · 42 studies	—	17 mo11–29 · 42 studies
Observational	32 mo21–49 · 44 studies	—	—

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 13, 2026.

Stopped1

Trial of Novel Regimens for the Treatment of Pulmonary TuberculosisSuspendedNov 2, 2026NCT06192160

Newly registered4

Vitamin D3 and Monocyte Responses in Pregnant Women With Pulmonary TuberculosisOct 30, 2026NCT07907094
Effect of Vitamin D and Zinc Supplementation on Inflammatory Biomarkers in Pulmonary Tuberculosis PatientsOct 27, 2026NCT07899138
BRIGHT-Child TB: Short-Course Treatment for Non-Severe Pulmonary Tuberculosis in ChildrenOct 26, 2026NCT07893444
Channa Striata and Curcuma Domestica Supplementation in Patients With Active Pulmonary TuberculosisOct 21, 2026NCT07887724

Studies

Recruiting first, then most recently updated. Showing 50 of 319. Browse all 319 → or search them.